The University of Rochester Medical Center and Rochester Regional Health have been chosen as one of four sites participating clinical trials involving an experimental COVID-19 vaccine.
Pfizer and and BioNTech are collaborating with URMC and RRH along with NYU Grossman School of Medicine the University of Maryland School of Medicine and Cincinnati Children’s Hospital Medical Center on this vaccine study.
The study will involve a total of 360 people in two age groups 18 to 55 and 65-85.
Dr. Ed Walsh from Rochester Regional Health says they already have people in this area willing to participate in the trial.
Clinical trials are already underway in Germany.